Philip Morris is leading the industry transition to smoke-free products, with 42% of revenue now from alternatives like IQOS and Zyn. Strong Q1 2025 results—10.2% organic revenue growth, rising margins, and raised earnings guidance—demonstrate robust financial health and execution. Despite a premium valuation and some regulatory and competitive risks, PM's stable cash flow and dividend growth justify a strong buy rating.
PM's market leadership in the tobacco market across combustible and smoke-free approaches has been well rewarded indeed, as observed in the premium valuations and inflated stock prices. These have been well supported by the growing net revenues, the expanding shipment volumes, and the richer adj operating margins, significantly aided by the US FDA approval for ZYN. This is on top of the rich cash flow story, with PM's dividend remaining safe despite the management's intensified US-based capex thus far.
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock?
![]() PM In 2 weeks Estimated | Quarterly | $1.35 Per Share |
![]() PM 2 months ago Paid | Quarterly | $1.35 Per Share |
![]() PM 5 months ago Paid | Quarterly | $1.35 Per Share |
![]() PM 8 months ago Paid | Quarterly | $1.35 Per Share |
![]() PM 11 months ago Paid | Quarterly | $1.3 Per Share |
![]() PM 20 Mar 2024 Paid | Quarterly | $1.3 Per Share |
21 Jul 2025 (48 Days) Date | | - Cons. EPS | - EPS |
21 Apr 2025 Date | | - Cons. EPS | - EPS |
6 Feb 2025 Date | | 1.5 Cons. EPS | 1.55 EPS |
22 Oct 2024 Date | | 1.82 Cons. EPS | 1.91 EPS |
23 Jul 2024 Date | | 1.57 Cons. EPS | 1.59 EPS |
![]() PM In 2 weeks Estimated | Quarterly | $1.35 Per Share |
![]() PM 2 months ago Paid | Quarterly | $1.35 Per Share |
![]() PM 5 months ago Paid | Quarterly | $1.35 Per Share |
![]() PM 8 months ago Paid | Quarterly | $1.35 Per Share |
![]() PM 11 months ago Paid | Quarterly | $1.3 Per Share |
![]() PM 20 Mar 2024 Paid | Quarterly | $1.3 Per Share |
21 Jul 2025 (48 Days) Date | | - Cons. EPS | - EPS |
21 Apr 2025 Date | | - Cons. EPS | - EPS |
6 Feb 2025 Date | | 1.5 Cons. EPS | 1.55 EPS |
22 Oct 2024 Date | | 1.82 Cons. EPS | 1.91 EPS |
23 Jul 2024 Date | | 1.57 Cons. EPS | 1.59 EPS |
Tobacco Industry | Consumer Defensive Sector | Mr. Jacek Olczak CEO | XWBO Exchange | US7181721090 ISIN |
US Country | 83,100 Employees | 20 Mar 2025 Last Dividend | - Last Split | 17 Mar 2008 IPO Date |